Social and Medical Aspects of Drug Abuse

[1]  R. Rawson,et al.  Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare. , 1984, Advances in alcohol & substance abuse.

[2]  A. Washton,et al.  Clonidine in Opiate Withdrawal: Review and Appraisal of Clinical Findings , 1981, Pharmacotherapy.

[3]  A. Washton,et al.  LOFEXIDINE, A CLONIDINE ANALOGUE EFFECTIVE IN OPIATE WITHDRAWAL , 1981, The Lancet.

[4]  H. Joseph,et al.  LONG‐TERM OUTCOMES AFTER TERMINATION FROM METHADONE MAINTENANCE TREATMENT * , 1981, Annals of the New York Academy of Sciences.

[5]  A. Washton,et al.  Psychotherapy and naltrexone in opioid dependence. , 1981, NIDA research monograph.

[6]  A. Washton,et al.  CLONIDINE VERSUS METHADONE FOR OPIATE DETOXIFICATION , 1980, The Lancet.

[7]  R. Rawson,et al.  CLONIDINE FOR OUTPATIENT OPIATE DETOXIFICATION , 1980, The Lancet.

[8]  H. Lal,et al.  Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat , 1980, Pharmacology Biochemistry and Behavior.

[9]  A. Goldstein,et al.  The naloxone test for opiate dependence , 1980, Clinical pharmacology and therapeutics.

[10]  J. Volavka,et al.  Quantitative determination of 2-hydroxy-3-methoxy-6 beta-naltrexol (HMN), naltrexone, and 6 beta-naltrexol in human plasma, red blood cells, saliva, and urine by gas liquid chromatography. , 1980, Journal of analytical toxicology.

[11]  M. Jarvik,et al.  Conditioned responses to a videotape showing heroin-related stimuli. , 1980, The International journal of the addictions.

[12]  A. Washton,et al.  Clonidine for opiate detoxification: outpatient clinical trials. , 1980, The American journal of psychiatry.

[13]  G. Woody,et al.  Development of psychiatric illness in drug abusers. Possible role of drug preference. , 1979, The New England journal of medicine.

[14]  B. Singer,et al.  On the Evaluation of Treatments for Narcotics Addiction , 1979 .

[15]  K. Verebey,et al.  Naltrexone, 6 beta-naltrexol and 2-hydroxy-3-methoxy-6 beta-naltrexol plasma levels in schizophrenic patients after large oral doses of naltrexone. , 1979, NIDA research monograph.

[16]  M. Gold,et al.  Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. , 1979, The American journal of psychiatry.

[17]  R. Rawson,et al.  Clonidine hydrochloride: a nonopiate treatment for opiate withdrawal. , 1979, NIDA research monograph.

[18]  D. Redmond,et al.  CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS , 1978, The Lancet.

[19]  B. Kissin,et al.  PATIENT ACCEPTABILITY AND CLINICAL APPLICABILITY OF ALTERNATIVE TREATMENT METHODS , 1978, Annals of the New York Academy of Sciences.

[20]  M. Gold,et al.  Clonidine for opiate withdrawal. , 1979, The Medical letter on drugs and therapeutics.

[21]  Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists. , 1978, Archives of general psychiatry.

[22]  P. Whitehead.  Acupuncture in the treatment of addiction: a review and analysis. , 1978, The International journal of the addictions.

[23]  A. Comfort.  MORPHINE AS AN ANTIPSYCHOTIC Relevance of a 19th-Century Therapeutic Fashion , 1977, The Lancet.

[24]  J. C. Kramer.  Heroin in the Treatment of Morphine Addiction , 1977 .

[25]  A. Washton,et al.  Naloxone‐precipitated withdrawal: A method for rapid induction onto naltrexone , 1977, Clinical pharmacology and therapeutics.

[26]  C. O'brien,et al.  Conditioned narcotic withdrawal in humans. , 1977, Science.

[27]  C. D. Copemann.  Treatment of polydrug abuse and addiction by covert sensitization: some contraindications. , 1977, The International journal of the addictions.

[28]  H. Kleber.  Detoxification from methadone maintenance: the state of the art. , 1977, The International journal of the addictions.

[29]  H L Wen,et al.  Fast detoxification of heroin addicts by acupuncture and electrical stimulation (AES) in combination with naloxone. , 1977, Comparative medicine East and West.

[30]  J. Volavka,et al.  Naltrexone: Disposition, metabolism, and effects after acute and chronic dosing , 1976, Clinical pharmacology and therapeutics.

[31]  D. Julius.  NIDA's naltrexone research program. , 1976, NIDA research monograph.

[32]  R. Meyer,et al.  Limitations of an extinction approach to narcotic antagonist treatment. , 1976, NIDA research monograph.

[33]  H. Lal,et al.  Naloxone antagonism of conditioned hyperthermia: an evidence for release of endogenous opioid. , 1976, Life sciences.

[34]  A. Goldstein.  Heroin Addiction: Sequential Treatment Employing Pharmacologic Supports , 1976 .

[35]  CLINICAL PHARMACOLOGY OF NALTREXONE , 1976 .

[36]  P. Renault,et al.  Narcotic Antagonists: Naltrexone Progress Report: NIDA Research Monograph 9: (497452006-001) , 1976 .

[37]  R. Meyer,et al.  Opiate antagonists and the modification of heroin self-administration behavior in man: an experimental study. , 1976, The International journal of the addictions.

[38]  J. Langrod,et al.  Detoxification of long-term methadone patients: problems and prospects. , 1976, The International journal of the addictions.

[39]  C. O'brien.  Experimental analysis of conditioning factors in human narcotic addiction. , 1975, Pharmacological reviews.

[40]  J. Mintz,et al.  Conditioning of narcotic abstinence symptoms in human subjects. , 1975, Drug and alcohol dependence.

[41]  S. Mulé,et al.  Isolation and identification of a new metabolite of naltrexone in human blood and urine. , 1975, Research communications in chemical pathology and pharmacology.

[42]  S. Siegel,et al.  Evidence from rats that morphine tolerance is a learned response. , 1975, Journal of comparative and physiological psychology.

[43]  F. Tennant,et al.  Heroin detoxification. A comparison of propoxyphene and methadone. , 1975, JAMA.

[44]  D. A. Callner.  Behavioral treatment approaches to drug abuse: a critical review of the research. , 1975, Psychological bulletin.

[45]  J. Cautela,et al.  The Use of Covert Conditioning in the Treatment of Drug Abuse , 1975 .

[46]  J. Mintz,et al.  Clinical experience with naltrexone. , 1975, The American journal of drug and alcohol abuse.

[47]  D. Lewis.  The clinical usefulness of narcotic antagonists: preliminary findings on the use of naltrexone. , 1975, The American journal of drug and alcohol abuse.

[48]  Z. Taintor,et al.  Experiences with Naltrexone in Buffalo. , 1975, The American journal of drug and alcohol abuse.

[49]  A. Schecter.  Clinical use of naltrexone (EN 1639 A). Part II: experience with the first 50 patients in a New York City treatment clinic. , 1975, The American journal of drug and alcohol abuse.

[50]  A. Freedman,et al.  Studies of EN-1639A (naltrexone): a new narcotic antagonist. , 2015, The American journal of psychiatry.

[51]  C. C. Whitehead.  Methadone Pseudowithdrawal Syndrome: Paradigm for a Psychopharmacological Model of Opiate Addiction , 1974, Psychosomatic medicine.

[52]  D. G. Levine.  "Needle freaks": compulsive self-injection by drug users. , 1974, The American journal of psychiatry.

[53]  W. McAuliffe,et al.  A Test of Lindesmith's Theory of Addiction: The Frequency of Euphoria Among Long-Term Addicts , 1974, American Journal of Sociology.

[54]  J. Newmeyer,et al.  "I got a yen for that darvon-N": a pilot study on the use of propoxyphene napsylate in the treatment of heroin addiction. , 1974, The American journal of drug and alcohol abuse.

[55]  B. Maletzky.  Assisted covert sensitization for drug abuse. , 1974, The International journal of the addictions.

[56]  H. Kleber,et al.  The use of cyclazocine in treating narcotic addicts in a low-intervention setting. , 1974, Archives of general psychiatry.

[57]  A. Wikler,et al.  Conditioning of successive adaptive responses to the initial effects of drugs , 1973, Conditional reflex.

[58]  D. Jasinski,et al.  Naltrexone, an antagonist for the treatment of heroin dependence. Effects in man. , 1973, Archives of general psychiatry.

[59]  A. Wikler,et al.  Dynamics of drug dependence. Implications of a conditioning theory for research and treatment. , 1973, Archives of general psychiatry.

[60]  P. Wisocki.  The successful treatment of a heroin addict by covert conditioning techniques , 1973 .

[61]  J. Teasdale.  Conditioned abstinence in narcotic addicts. , 1973, The International journal of the addictions.

[62]  M Snow,et al.  Maturing out of narcotic addiction in New York City. , 1973, The International journal of the addictions.

[63]  H. Blumberg,et al.  Naloxone, naltrexone, and related noroxymorphones. , 1973, Advances in biochemical psychopharmacology.

[64]  H. J. Grosz,et al.  Narcotic withdrawal symptoms in heroin users treated with propranolol. , 1972, Lancet.

[65]  J. O'Brien,et al.  Treatment of heroin addiction with aversion therapy, relaxation training and systematic desensitization. , 1972, Behaviour research and therapy.

[66]  A. Freedman,et al.  Cyclazocine treatment of opiate dependence: a progress report. , 1971, Comprehensive psychiatry.

[67]  A. Freedman,et al.  Naloxone treatment of opiate dependence. A progress report. , 1971, JAMA.

[68]  S. Goldberg,et al.  Conditioned nalorphine-induced abstinence changes: persistence in post morphine-dependent monkeys. , 1970, Journal of the experimental analysis of behavior.

[69]  A. Freedman,et al.  A cyclazocine typology in opiate dependence. , 1970, The American journal of psychiatry.

[70]  F. Foldes,et al.  The respiratory, circulatory, and narcotic antagonistic effects of nalorphine, levallorphan, and naloxone in anaesthetized subjects , 1969, Canadian Anaesthetists' Society journal.

[71]  T. Kraft.  Treatment of Drinamyl Addiction , 1969 .

[72]  C. Haertzen,et al.  The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone). , 1967, The Journal of pharmacology and experimental therapeutics.

[73]  W. Martin.  Opioid antagonists. , 1967, Pharmacological reviews.

[74]  Jaffe Jh.  Cyclazocine in the treatment of narcotic addiction. , 1967 .

[75]  W. Martin,et al.  An experimental study in the treatment of narcotic addicts with cyclazocine , 1966, Clinical pharmacology and therapeutics.

[76]  V. Dole,et al.  A Medical Treatment for Diacetylmorphine (Heroin) Addiction , 1966 .

[77]  J. Lunn,et al.  N‐ALLYLNOROXYMORPHONE: A NEW POTENT NARCOTIC ANTAGONIST , 1963 .

[78]  H. Cleckley,et al.  Use of electric-convulsive therapy in morphine, meperidine, and related alkaloid addictions. , 1953, A.M.A. archives of neurology and psychiatry.

[79]  J. D. Elder,et al.  N-ALLYL-NORMORPHINE IN THE TREATMENT OF MORPHINE OR DEMEROL NARCOSIS , 1952, The American journal of the medical sciences.

[80]  H. Isbell,et al.  The addiction liability of methadon (amidone, dolophine, 10820) and its use in the treatment of the morphine abstinence syndrome. , 1949, The American journal of psychiatry.

[81]  H. Isbell,et al.  Liability of addiction to 6-dimethylamino-4-4-diphenyl-3-heptanone (methadon, amidone or 10820) in man; experimental addiction to methadon. , 1948, Archives of internal medicine.

[82]  L. Kolb,et al.  CLINICAL STUDIES OF DRUG ADDICTION, III , 1938 .